Unicycive Therapeutics, Inc. (UNCY)

Unicycive Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	42.7	26.14	9.7	0.46	16.58	-
Cash & Short-Term Investments	42.7	26.14	9.7	0.46	16.58	-
Cash Growth	31.99%	169.48%	2032.09%	-97.26%	-	-
Prepaid Expenses	6.71	3.87	3.37	2.03	1.71	-
Other Current Assets	0.88	0.94	0.33	0.16	0.13	0.2
Total Current Assets	50.29	30.95	13.4	2.64	18.41	0.2
Property, Plant & Equipment	0.32	0.72	0.79	0.17	0.33	-
Total Assets	50.61	31.67	14.19	2.82	18.74	0.2
Accounts Payable	0.96	1.06	0.84	0.89	0.74	0.18
Accrued Expenses	2.76	3.56	3.23	2.24	1.21	0.18
Short-Term Debt	-	-	-	-	-	2.51
Current Portion of Leases	0.27	0.56	0.33	0.16	0.15	-
Other Current Liabilities	9.15	18.94	13.13	-	-	-
Total Current Liabilities	13.13	24.12	17.53	3.28	2.11	2.88
Long-Term Leases	-	0.12	0.47	-	0.16	-
Total Liabilities	13.13	24.24	18	3.28	2.26	2.88
Common Stock	0.02	0.11	0.04	0.02	0.02	0.01
Additional Paid-In Capital	150.62	108.59	60.7	33.52	32.41	3.24
Retained Earnings	-113.16	-101.27	-64.54	-34	-15.94	-5.92
Shareholders' Equity	37.48	7.43	-3.81	-0.47	16.48	-2.67
Total Liabilities & Equity	50.61	31.67	14.19	2.82	18.74	0.2
Total Debt	0.27	0.68	0.79	0.16	0.31	2.51
Net Cash (Debt)	42.43	25.46	8.91	0.3	16.27	-2.51
Net Cash Growth	34.53%	185.82%	2869.33%	-98.16%	-	-
Net Cash Per Share	3.22	3.80	3.63	0.20	13.94	-2.96
Filing Date Shares Outstanding	21.49	11.97	3.48	1.52	1.5	0.89
Total Common Shares Outstanding	20.85	11.38	3.48	1.52	1.5	0.85
Working Capital	37.16	6.83	-4.14	-0.64	16.31	-2.67
Book Value Per Share	1.80	0.65	-1.10	-0.31	10.99	-3.14
Tangible Book Value	37.48	7.43	-3.81	-0.47	16.48	-2.67
Tangible Book Value Per Share	1.80	0.65	-1.10	-0.31	10.99	-3.14
Machinery	0.07	0.06	0.02	0.01	0.01	-
Construction In Progress	-	0.01	-	-	-	-
Leasehold Improvements	0.07	0.05	0.02	0.02	0.02	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q